Ra Medical Systems Stock Fundamentals
Fundamental analysis of RA Medical allows traders to better anticipate movements in RA Medical's stock price by examining its financial health and performance throughout various phases of its business cycle.
RMED |
RA Medical Systems Company Return On Equity Analysis
RA Medical's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current RA Medical Return On Equity | -3.25 |
Most of RA Medical's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RA Medical Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, RA Medical Systems has a Return On Equity of -3.2525. This is 86.43% lower than that of the Health Care Equipment & Supplies sector and 62.74% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
RA Medical Systems Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining RA Medical's current stock value. Our valuation model uses many indicators to compare RA Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across RA Medical competition to find correlations between indicators driving RA Medical's intrinsic value. More Info.RA Medical Systems is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value RA Medical by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.RMED Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses RA Medical's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of RA Medical could also be used in its relative valuation, which is a method of valuing RA Medical by comparing valuation metrics of similar companies.RA Medical is currently under evaluation in return on equity category among its peers.
RMED Fundamentals
| Return On Equity | -3.25 | |||
| Return On Asset | -0.48 | |||
| Operating Margin | (307.60) % | |||
| Current Valuation | (8.89 M) | |||
| Shares Outstanding | 6.46 M | |||
| Shares Owned By Insiders | 36.84 % | |||
| Shares Owned By Institutions | 11.00 % | |||
| Number Of Shares Shorted | 81.45 K | |||
| Price To Book | 0.86 X | |||
| Price To Sales | 604.06 X | |||
| Revenue | 14 K | |||
| Gross Profit | (1.54 M) | |||
| EBITDA | (18.2 M) | |||
| Net Income | (26.86 M) | |||
| Cash And Equivalents | 13.66 M | |||
| Cash Per Share | 9.60 X | |||
| Total Debt | 124.17 K | |||
| Debt To Equity | 0.16 % | |||
| Current Ratio | 4.83 X | |||
| Book Value Per Share | 6.81 X | |||
| Cash Flow From Operations | (22.57 M) | |||
| Short Ratio | 0.13 X | |||
| Earnings Per Share | (35.78) X | |||
| Target Price | 7.0 | |||
| Number Of Employees | 14 | |||
| Beta | 0.18 | |||
| Market Capitalization | 3.84 M | |||
| Total Asset | 16.84 M | |||
| Retained Earnings | (205.14 M) | |||
| Working Capital | 9.26 M | |||
| Z Score | -1.42 | |||
| Net Asset | 16.84 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in RMED Stock
If you are still planning to invest in RA Medical Systems check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RA Medical's history and understand the potential risks before investing.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |